Total Treatment Options
50
|
In Development
30
|
|
Under Clinical Trials
20
|
Treat Symptoms
5
|
Anti-inflammatory
8
|
Anti-viral growth
6
|
Passive Immunization
1
|
Number of Clinical Trials
80
|
Observational
2 |
|
Phase I - Safety/Side-Effects, Dose
6 |
|
Phase I/II
1 |
|
Phase II - Effectiveness/safety
16 |
|
Phase II/III
7 |
|
Phase III - Confirm effectiveness
21 |
|
Phase IV - Risk-benefit/best use
11 |
|
Completed
1 |
|
Phase Not Mentioned
15 |
